SCHEDULE 13D/A

ESSA PHARMA INC

Common Stock · CUSIP: 29668H708

Event date: 2025-07-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• SOLEUS CAPITAL MASTER FUND, L.P.Reported CIK 0001812275

  Shares: 4,362,026.00 · Class: 9.8%

• SOLEUS CAPITAL, LLC

  Shares: 4,362,026.00 · Class: 9.8%

• SOLEUS CAPITAL GROUP, LLC

  Shares: 4,362,026.00 · Class: 9.8%

• SOLEUS CAPITAL MANAGEMENT, L.P.

  Shares: 4,362,026.00 · Class: 9.8%

• SOLEUS GP, LLC

  Shares: 4,362,026.00 · Class: 9.8%

• GUY LEVY

  Shares: 4,362,026.00 · Class: 9.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.